Search - tctmd.com

Displaying 361 - 380 of 390

Presentation TCT 2012

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Presenter: Jung-Won Suh, Gary S. Mintz, Giora Weisz, Akiko Maehara, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Safety and Efficacy of the Resolute Zotarolimus-eluting Stent in Patients ? 70 Years of Age.

Presenter: Ganesh Manoharan, Alan C. Yeung, Petr Widimsky, Franz-Josef Neumann, Patrick W. Serruys, Sigmund Silber, Stephan Windecker, Martin B. Leon, Laura Mauri, Shigeru Saito, Ian T. Meredith, Jorge Belardi

January 03, 2012

Presentation TCT 2012

Relationship Between Plaque Composition Assessed With Radiofrequency IVUS and Clinical Outcomes in Patients with Acute Coronary Syndromes and Diabetes Mellitus or Metabolic...

Presenter: Steven P. Marso, Nestor Mercado, Akiko Maehara, Giora Weisz, Gary Mintz, John McPherson, Francois Schiele, Dariusz Dudek, Martin Fahy, Ke Xu, Alexandra Lansky, Bernard de Bruyne, Patrick Serruys, Gregg Stone

January 03, 2012

Presentation TCT 2012

Quantitative multi-modality imaging analysis of a fully bioresorbable scaffold: a head-to-head comparison between QCA, IVUS and OCT

Presenter: Juan Luis Guti?rrez-Chico, Patrick W. Serruys, Chrysafios Girasis, Yoshinobu Onuma, Salvatore Brugaletta, H?ctor Manuel Garc?a-Garc?a, Evelyn Regar

January 03, 2012

Presentation TCT 2012

Incidence, timing and predictors of valve dislodgment during TAVI with the Medtronic Corevalve System

Presenter: Nicolas M. Van Mieghem, Carl J. Schultz, Robert M. van der Boon, Rutger-Jan Nuis, Apostolos Tzikas, Marcel L. Geleijnse, Ron T. van Domburg, Patrick W. Serruys, Peter P. de Jaegere

January 03, 2012

Presentation TCT 2012

In Vivo Characterization of Bioresorbable Vascular Scaffold Strut Interfaces Using Optical Coherence Tomography with Gaussian Line Spread Function Analysis

Presenter: Alexander Sheehy, Juan Luis Guti?rrez-Chico, Roberto Diletti, James P Oberhauser, Thierry Glauser, Joel Harrington, Mary Beth Kossuth, Richard J Rapoza, Yoshinobu Onuma, Patrick W. Serruys

January 03, 2012

Presentation TCT 2012

Impact of Renal Impairment on Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents: a Pooled Analysis of SIRTAX, LEADERS, and...

Presenter: Giulio G. Stefanini, Bindu Kalesan, Lorenz Raber, Thomas Pilgrim, Yoshinobu Onuma, Sigmund Silber, Patrick W. Serruys, Bernhard Meier, Peter Juni, Stephan Windecker

January 03, 2012

Presentation TCT 2012

Four-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease and/or Left Main Disease

Presenter: David R. Holmes, Brad Vazales, Louis A. Cannon, Elisabeth Stahle, Marie-Claude Morice, Michael J. Mack, Ted E. Feldman, A. Pieter Kappetein, Antonio Colombo, Keith D. Dawkins, Friedrich W. Mohr, Patrick W. Serruys

January 03, 2012

Presentation TCT 2012

Extent, Characterization, and Clinical Implications of Untreated Lesions with High Plaque Burden after Successful Percutaneous Coronary Intervention: A PROSPECT Substudy.

Presenter: John A. McPherson, Akiko Maehara, Giora Weisz, Gary S. Mintz, Ecaterina Cristea, Roxana Mehran, Michael Foster, Stefan Verheye, Leroy Rabbani, Ke Xu, Martin Fahy, Alexandra J. Lansky, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Clinical Outcome following Transcatheter Aortic Valve Implantation in Patients with Impaired Left Ventricular Systolic Function

Presenter: Robert M. van der Boon, Rutger-Jan Nuis, Nicolas M. van Mieghem, Luis M. Benitez, Robert-Jan van Geuns, Tjebbe W. Galema, Ron T. van Domburg, Patrick W. Serruys, Eduardo de Marchena, Marcel L. Geleijnse, Antonio E. Dager, Peter P. de Jaegere

January 03, 2012

Presentation TCT 2012

Assessment of Atherosclerosis at Coronary Bifurcations with Multislice Computed Tomography and Intravascular Ultrasound-Virtual Histology.

Presenter: Stella-Lida Papadopoulou, Salvatore Brugaletta, Hector M. Garcia-Garcia, Pim J. de Feyter, Patrick W. Serruys

January 03, 2012

Presentation TCT 2012

Age and Sex Related Plaque Composition Of Non Culprit Lesions In Patients with Acute Coronary Syndromes: The PROSPECT Study.

Presenter: Juan Ruiz Garc?a, Amir Lerman, Giora Weisz, Akiko Maehara, Gary S. Mintz, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Tony G. Farah, Rui Teles, Hans Botker, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Conference News

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Caitlin E. Cox

May 20, 2011

News Industry News

Plans For Largest Ever Drug-Eluting Stent Randomized Clinical Trial Announced at EuroPCR

May 18, 2011

News Industry News

InfraReDx Receives CE Mark Approval In EU For LipiScan IVUS Coronary Imaging System

April 21, 2011

Advertisement

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Safety and Efficacy of the Resolute Zotarolimus-eluting Stent in Patients ? 70 Years of Age.

Relationship Between Plaque Composition Assessed With Radiofrequency IVUS and Clinical Outcomes in Patients with Acute Coronary Syndromes and Diabetes Mellitus or Metabolic...

Quantitative multi-modality imaging analysis of a fully bioresorbable scaffold: a head-to-head comparison between QCA, IVUS and OCT

Incidence, timing and predictors of valve dislodgment during TAVI with the Medtronic Corevalve System

In Vivo Characterization of Bioresorbable Vascular Scaffold Strut Interfaces Using Optical Coherence Tomography with Gaussian Line Spread Function Analysis

Impact of Renal Impairment on Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents: a Pooled Analysis of SIRTAX, LEADERS, and...

Four-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease and/or Left Main Disease

Extent, Characterization, and Clinical Implications of Untreated Lesions with High Plaque Burden after Successful Percutaneous Coronary Intervention: A PROSPECT Substudy.

Clinical Outcome following Transcatheter Aortic Valve Implantation in Patients with Impaired Left Ventricular Systolic Function

Assessment of Atherosclerosis at Coronary Bifurcations with Multislice Computed Tomography and Intravascular Ultrasound-Virtual Histology.

Age and Sex Related Plaque Composition Of Non Culprit Lesions In Patients with Acute Coronary Syndromes: The PROSPECT Study.

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

SYNTAX at 4 Years: PCI and CABG Equivalent in Left Main Disease

Novel Imaging Modality Used to Assess Effect of Thrombus Aspiration in STEMI

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

Clinical Variables Added to Syntax Score Increases Predictive Ability

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Plans For Largest Ever Drug-Eluting Stent Randomized Clinical Trial Announced at EuroPCR

InfraReDx Receives CE Mark Approval In EU For LipiScan IVUS Coronary Imaging System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content